Status:
RECRUITING
Efficacy of Ultraviolet Germicidal Irradiation Devices to Reduce Respiratory Infections in Nursing Homes: Cluster Randomized Crossover Trial
Lead Sponsor:
Centre Hospitalier Emile Roux
Collaborating Sponsors:
ANRS | French National Research Agency on Emerging Infectious Diseases
Conditions:
Acute Respiratory Infections
Eligibility:
All Genders
Phase:
NA
Brief Summary
RESPROTECT is a trial aimed at evaluating the effectiveness of upper room ultraviolet devices in reducing the frequency of severe respiratory infections in elderly nursing homes. The study takes place...
Detailed Description
The objective of this clinical trial is to determine whether ultraviolet germicidal irradiation (UVGI) can decrease the frequency of severe acute respiratory infections in elderly people living in nur...
Eligibility Criteria
Inclusion
- Center Inclusion criteria:
- Elderly Nursing homes (ENH):
- Having a system for monitoring cases of upper and lower respiratory infections among their residents.
- Agreeing to take part in the study
- Undertaking to comply with the protocol
- Accepting the installation of UVGI devices
- Undertaking to provide all residents or their legal guardians/curators with an individual information leaflet.
Exclusion
- ENH:
- Not wishing to be equipped with UVGI devices in all rooms considered necessary to be equipped by the investigators
- Having planned a major change to the structure (extension, renovation, closure, requalification, etc.) during the course of the study, which could affect the study population and/or UVGI air treatment devices.
- Individual Inclusion criteria:
- All residents present in one of the participating ENH at the start of each of the two study periods, or arriving in one of the participating ENH during one of the two periods, will be eligible
- Individual Exclusion criteria :
- Residents of the ENH included in the study who have expressed (personally or through a relative or legal representative) the wish that their personal data not be used for the study will not be included in the study.
Key Trial Info
Start Date :
October 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2026
Estimated Enrollment :
1200 Patients enrolled
Trial Details
Trial ID
NCT06569160
Start Date
October 1 2024
End Date
June 1 2026
Last Update
December 8 2025
Active Locations (12)
Enter a location and click search to find clinical trials sorted by distance.
1
EHPAD Notre Dame
Beaulieu, France, 43021
2
EHPAD du Centre hospitalier du Pays de Craponne sur Arzon
Craponne-sur-Arzon, France, 43500
3
EHPAD Paradis
Espaly-Saint-Marcel, France, 43000
4
EHPAD du Centre hospitalier Pierre Gallice
Langeac, France, 43300